We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis.

Science (New York, N.Y.) | Dec 1, 2000

The members of the ADAR (adenosine deaminase acting on RNA) gene family are involved in site-selective RNA editing that changes adenosine residues of target substrate RNAs to inosine. Analysis of staged chimeric mouse embryos with a high contribution from embryonic stem cells with a functional null allele for ADAR1 revealed a heterozygous embryonic-lethal phenotype. Most ADAR1+/- chimeric embryos died before embryonic day 14 with defects in the hematopoietic system. Our results suggest the importance of regulated levels of ADAR1 expression, which is critical for embryonic erythropoiesis in the liver.

Pubmed ID: 11099415 RIS Download

Mesh terms: Adenosine Deaminase | Alleles | Animals | Chimera | Embryonic and Fetal Development | Erythroblasts | Erythropoiesis | Female | Hematopoietic Stem Cells | Hepatocytes | Immunoenzyme Techniques | Liver | Mice | Mice, Inbred BALB C | Mice, SCID | Phenotype | RNA Editing | RNA-Binding Proteins | Stem Cells | Teratoma

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants


Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.